BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30699183)

  • 1. Prognostic factors associated with survival in patients with anaplastic oligodendroglioma.
    Liu S; Liu X; Xiao Y; Chen S; Zhuang W
    PLoS One; 2019; 14(1):e0211513. PubMed ID: 30699183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
    Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of radiotherapy for elderly patients with anaplastic gliomas.
    Mukherjee D; Sarmiento JM; Nosova K; Boakye M; Lad SP; Black KL; Nuño M; Patil CG
    J Clin Neurosci; 2014 May; 21(5):773-8. PubMed ID: 24355207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Overall Survival Prognostic Nomogram for Oligodendroglioma: A Surveillance, Epidemiology, and End Results Population-Based Analysis.
    Cao L; Rong P; Zhu G; Xu A; Chen S
    World Neurosurg; 2021 Jul; 151():e810-e820. PubMed ID: 33964496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicohistological study of oligodendroglioma and oligoastrocytoma.
    Tamura M; Zama A; Kurihara H; Kano T; Imai H; Ishiuchi S; Iwai T; Naito I
    Brain Tumor Pathol; 1997; 14(1):35-9. PubMed ID: 9384800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated therapeutic strategy for adult low-grade glioma stratified by resection and tumor subtype.
    Nitta M; Muragaki Y; Maruyama T; Iseki H; Ikuta S; Konishi Y; Saito T; Tamura M; Chernov M; Watanabe A; Okamoto S; Maebayashi K; Mitsuhashi N; Okada Y
    Neurol Med Chir (Tokyo); 2013; 53(7):447-54. PubMed ID: 23883555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951.
    Gorlia T; Delattre JY; Brandes AA; Kros JM; Taphoorn MJ; Kouwenhoven MC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ
    Eur J Cancer; 2013 Nov; 49(16):3477-85. PubMed ID: 23896377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of oligodendroglial tumors based on histopathology criteria is a significant predictor of survival--clinical, radiological and pathologic long-term follow-up analysis.
    Sepulveda Sanchez JM; Martinez Montero JC; Diez-Lobato R; Hernandez-Lain A; Cabello A; Ramos A; Gonzalez Leon P; Ricoy Campo JR
    Clin Neuropathol; 2009; 28(1):11-20. PubMed ID: 19216215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era.
    Sakata K; Hareyama M; Komae T; Shirato H; Watanabe O; Watarai J; Takai K; Yamada S; Tsuchida E; Sakai K
    Jpn J Clin Oncol; 2001 Jun; 31(6):240-5. PubMed ID: 11463800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.
    Taghian A; Ramsay J; Allalunis-Turner J; Budach W; Gioioso D; Pardo F; Okunieff P; Bleehen N; Urtasun R; Suit H
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):243-9. PubMed ID: 8380568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What progress has been made in surgical management of patients with astrocytoma and oligodendroglioma in Australia over the last two decades?
    Smith SF; Simpson JM; Sekhon LH
    J Clin Neurosci; 2005 Nov; 12(8):915-20; discussion 921. PubMed ID: 16326271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postoperative radiotherapy of supratentorial anaplastic glioma].
    Wendt TG; Bacherler B; Baumer K; Rohloff R; Willich N
    Strahlenther Onkol; 1986 Jun; 162(6):347-53. PubMed ID: 3738736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and patterns of care in elderly patients with glioma.
    Iwamoto FM; Reiner AS; Nayak L; Panageas KS; Elkin EB; Abrey LE
    Cancer; 2009 Dec; 115(23):5534-40. PubMed ID: 19708033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of resection and survival for oligodendroglioma: a U.S. population-based study.
    Kinslow CJ; Garton ALA; Rae AI; Marcus LP; Adams CM; McKhann GM; Sisti MB; Connolly ES; Bruce JN; Neugut AI; Sonabend AM; Canoll P; Cheng SK; Wang TJC
    J Neurooncol; 2019 Sep; 144(3):591-601. PubMed ID: 31407129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
    Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
    J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.
    van Veelen ML; Avezaat CJ; Kros JM; van Putten W; Vecht C
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):581-7. PubMed ID: 9598670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.